By Nigam Arora & Dr. Natasha Arora
KBH is long from $16.15. It is trading at $39.02. This represents a gain of 141%.
Here are the key points applicable to KBH:
- KBH is a home builder.
- Demand for housing in the price range and the geographic locations where KBH builds is strong.
- We shared with you in the Morning Capsule that the 10-year Treasury note rose above 1.90%.
- As interest rates rise, the sentiment for home builders becomes negative.
Zones
For the foregoing reasons, the buy zone for KBH is being suspended. A new buy zone will be given when there is more clarity about the Fed policy.
The very long term target zone remains $66 – $71.
Buyout Candidate
KBH is a buyout candidate. To date, 171 of The Arora Report portfolio companies have been bought out producing a fortune for long time subscribers. This performance is better than boutique firms charging upwards of $50,000 per year.
What To Do Now
Those in the stock, as part of a diversified portfolio, may consider continue to hold for the time being.
Those not in the stock may consider waiting for a signal on the Real Time Feed.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
